News & Analysis on Clinical Trial Services & Contract Research And Development
The US Biomedical Advanced Research and Development Authority (BARDA) has awarded Novan $7.8 million to aid the development of what the company hopes will be the first FDA-approved drug with a burn healing indication.
Bioreliance has launched an updated version of its mutagenicity service after conducting studies that confirmed its Big Blue Mouse assay still meets OECD standards.
The EU’s CHMP(Committee for Medicinal Products for Human Use) will delay the application of a guideline that would set limits on metal catalysts or metal reagent residues until the ICH finalizes its own guideline on the issue.
OmniComm Systems and Clinverse have partnered to combine OmniComm’s EDC system with Clinverse’s automated payment tool.
The US FDA has sent a warning letter to CRO Drug Research and Analysis Corp. founder and president Henry Frazer for failing to adhere to the agency’s regulations governing clinical trials.
UK CRO Selcia has been contracted to develop antibiotics capable of tacking resistant superbugs by Cantab Anti-Infectives.